1. Volume 4, Issue 9, Pages 866-868 (October 2018)
Chronic verrucous sarcoidosis associated with human papillomavirus infection: Improvement with adalimumab 
Caroline E. Hagan, MD, Maureen Offiah, MD, Robert T. Brodell, MD, Jeremy D. Jackson, MD 
JAAD Case Reports 
Volume 4, Issue 9, Pages (October 2018)
DOI: /j.jdcr
Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Lesion at initial presentation shows annular verrucous lesions overlying sarcoidal papules and plaques.
JAAD Case Reports 2018 4, DOI: ( /j.jdcr )
Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
A, Lesion progression 2 years later. Worsening disease shows thickened annular verrucous lesions overlying sarcoidal changes despite a variety of treatments including cryotherapy, intralesional triamcinolone, hydroxycholorquine, methotrexate, and imiquimod. B, Close-up view of the right nasal sidewall and right cheek refractive to treatments noted in previous figure.
JAAD Case Reports 2018 4, DOI: ( /j.jdcr )
Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

4. Fig 3
A, Annular lesions 4 months after starting adalimumab treatment. Note significant improvement in background sarcoidosis papules and plaques in addition to thinning borders of verrucous lesions. B, Close-up view with near-complete thinning of the verrucous border and resolution of hyperpigmentated annular lesions 4 months after adalimumab initiation.
JAAD Case Reports 2018 4, DOI: ( /j.jdcr )
Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions